Close

Needham & Company Maintains a 'Hold' on Vertex (VRTX); AASLD Meeting Update Nov 8, 2011 09:15AM
Needham & Company Maintains a 'Hold' on Vertex (VRTX); Incivek Sales Exceed Expectations Again, But Growth Appears to Be Slowing Oct 28, 2011 08:46AM
Needham & Company Maintains a 'Hold' on Vertex (VRTX); Raising Incivek Sales Estimates, But Concerns Remain Sep 22, 2011 04:40PM
Notable Analyst Rating Changes 05/26: (HST) (FITB) (CTSH) Upgraded; (RSH) (LULU) (CAVM) Downgraded May 26, 2011 11:15AM
Needham & Company Maintains a 'Hold' on Vertex (VRTX); 1Q11 Review; Vertex Ready for Incivek Approval and Launch May 4, 2011 09:14AM


Apr 29, 2011 10:25AM Needham & Company Maintains a 'Hold' on Vertex (VRTX); Telaprevir Gets Enthusiastic Endorsement from FDA Advisory Committee, But Concerns Remain
Feb 23, 2011 12:33PM Needham & Company Maintains a 'Hold' on Vertex (VRTX); Positive VX-770 Phase 3 Outcome in CF, But High Investor Expectations for HCV Program
Sep 8, 2010 02:52PM Needham & Company Downgraded Vertex (VRTX) to Hold
May 26, 2010 07:39AM Needham & Company Reiterates a 'Buy' on Vertex Pharmaceuticals (VRTX); Encouraging Top-Line Results from Phase 3 ADVANCE Trial
Apr 22, 2010 07:57AM Needham & Company Reiterates a 'Buy' on Vertex Pharmaceuticals (VRTX); Room for Upside Around Phase 3 ADVANCE Results
Jan 12, 2010 08:42AM Needham & Co Reiterates a 'Buy' on Vertex Pharmaceuticals (VRTX); Raises Price Target
Sep 26, 2008 08:52AM Needham & Co Upgrades Vertex Pharmaceuticals (VRTX) to Buy